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Abstract 
Preimplanatation genetic diagnosis (PGD) allows genetic information to be tested 
after an egg is fertilized in vitro before implantation into the uterus.  The technology was 
first used to select for embryos at risk for X-linked diseases, however it has been observed 
that prospective parents are using this technology to select for the sex of their child based 
on preference.  This study aims to examine the views of genetic counselors towards the 
use of PGD for social sex selection purposes. A survey was conducted using the online 
website survey monkey’s platform and sent to members of the National Society of 
Genetic Counselors through their eblast. A majority of the respondents expressed that 
they were worried about the potential future of sex selection leading more offensive types 
of trait selection, and they feel that the use of reproductive technology to select trait is 
likely to become more commonplace over time.  They showed discomfort in counseling 
patients about social sex selection regardless of the patient’s age, ethnicity, or reasons 
such as family balancing.  Genetic counselors did not support termination of pregnancy 
for sex selection purposes, but felt strongly in the right of the patient to terminate a 
pregnancy regardless of the reason. Genetic counselors are concerned about their role in 
the current practice regarding social sex selection.  1.They have conflicting views that on 
one hand, they do not support pregnancy termination for social sex selection purposes, but 
on the other hand, they believe the right of the patient in terminating a pregnancy for any 
reason.  The result of this study suggests that perhaps a formal discussion should take 
place to explore the role of genetic counselors in this emerging area of patient service. 
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Background 
 Preimplantation genetic diagnosis (PGD) is a medical technique by which 
prospective parents can inform themselves about the genetic makeup of early embryos.  In 
some instances, it can be used for the purposes of sex selection, either for medical 
purposes or to obtain a child of the desired sex.  PGD’s first use was as a tool for sex 
selection, to select among embryos at risk for an X-linked disease (Delhanty, J. D., 1994).  
For most X-linked diseases, male embryos are at a 50% risk of being affected, and female 
embryos are at a 50% risk of being carriers.  Therefore, female embryos only were 
selected and implanted into the prospective mothers.    
 
 Since it first was developed in the 1980s, PGD has been used to select for single 
gene disorders such as Myotonic dystrophy, Huntington’s disease, Fragile X, B-
thalassemia, retinoblastoma, and spinal muscular dystrophy (Verlinsky, Y. et al, 2004). 
These uses have not been free of controversy.  Some argue that its use suggests a lack of 
respect and tolerance for people with disabilities (Macklin, R., 2010), while others believe 
that the pain and suffering experienced by children with genetic conditions and their 
families should triumph over all other arguments (Botkin, J. R.,1998).  Questions have 
been raised about where and how to draw the line on the use of PGD, with some 
suggesting that it be restricted and others deferring to the autonomy of the prospective 
parents in all situations (Macklin, R., 2010).  
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Ethical Issues around Terminations 
 PGD can be seen as unethical because it involves creating and discarding embryos.  
There are different stages of life, and the timing of any form of prenatal testing could 
make a significant difference in its ethical implications.  It has been argued that a 3-day 
old embryo is not the same as a 5 month old fetus, and hence discarding embryos and 
terminating fetuses should be viewed differently (Botkin, J. R., 1998; El-Toukhy, T. et al, 
2008).  PGD allows parents concerned about a risk of genetic disease to know ahead of 
time that the baby is unaffected, so that the anxiety associated with waiting for a prenatal 
diagnosis is avoided. It also should be noted that all pregnant women have the legal right 
to terminate their pregnancy for any reason before the legal cut-off time, which most of 
the time in the United States is 24 weeks gestation.  However, whatever one’s stand on 
abortion, it is generally agreed that for ethical and medical reasons, earlier termination – 
or the loss of an embryo before implantation– is a better outcome than a late termination. 
 
Population Imbalance 
 The use of this technique for social sex selection has raised its own ethical issues.  
Many argue that social sex selection is an act of sexism, and that the use of PGD for 
social selection provides no therapeutic benefit to the child (Robertson, J. A., 2001). 
Selection in favor of male fetuses is far more common worldwide, as seen in many 
countries where social sex selection practiced through termination has lead to population 
imbalances.   
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 In China, ultrasound technology became readily available to the public in the 1980s, 
and abortion for the purpose of sex-selection following prenatal ultrasound became a 
popular method to ensure the birth of a son.  The widespread use of this practice can be 
inferred by a look at sex imbalances in the population.  It is estimated that there will be an 
excess of 22 million men of reproductive age in China by 2025, and the consequences of 
this have already been felt (Greenhalgh, S., 2013).  Problems with “bride trafficking” 
have came to the government’s attention, with  girls in rural areas  being kidnapped and 
traded to other rural areas as brides to single men (Li SZ, Yan SH., 2008; Zhou, C., 2012). 
 
 In India, the first national analysis of sex-selective abortion trends, published in 
2011 (Jha, P., 2011), reported sex ratio differed significantly depending on the sex of the 
firstborn. Between 1991 and 2011, when the firstborn was a girl, the child sex ratio 
(number of females to every 1000 males) for ages 0-6 dropped by 1.5% on average.  
However, the child sex ratio for a second child did not differ from predicted norms when 
the firstborn was a boy.  By 2011, there were 7.1 million more boys between the ages of 
0-6 than girls (Jha, P., 2011).  The study also found that preference for sons had no 
relation to socioeconomic status, but selective abortion did.  More educated women from 
richer families were more likely to use sex-selective abortion.  This difference was 
attributed to greater access to medical services (Jha, P., 2011).  
 
 The availability of PGD could worsen the population imbalance problems in 
countries such as India and China.  However, wide scale use of PGD for sex selection 
might not be feasible in these countries for financial reasons, and the increased population 
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imbalance that is feared might not be relevant (Macklin, R., 2010).  The cost of a cycle of 
IVF cycle with PGD including the medication for the induction of ovulation is 
approximately $17,000 - $20,000 USD (Sherbahn, R., Accessed 2014). 
 
Family Balancing 
 Family balancing is an aspect of the use of PGD for social sex selection that is 
arguably more likely to be accepted by the general public.  Proponents suggest that it is 
not the desire for one sex over the other but a boy-girl balance that parents are seeking 
(El-Toukhy, T. et al 2008; Macklin, R., 2010; Pennings, G., 1996). Family balancing is 
less likely to be seen as sexist because parents with one or two children of the same sex 
want a child of an opposite sex.  If psychological studies support that there are biological 
differences between girls and boys, then arguably those interested to experience both 
should not be discouraged because of concerns about discrimination (Sermon, K. et al, 
2004). On the other hand, family balancing brings up the question of stereotyping gender.  
There’s a possibility that parents may put unnecessary pressure on the child to abide by 
gender stereotypes, and the disappointment in failing to meet such expectations may 
affect the parent-child relationship. 
 
Slippery Slope 
 A public opinion survey done in 2004 with a representative sample of 4,834 
Americans showed that 66% agreed with the use of PGD for fatal medical conditions, but 
a majority expressed concerns about the idea of “designer babies” and distrust in the 
morals of scientists developing advancements in technology.  53% agreed or strongly 
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agreed that “scientists these days don't pay enough attention to the moral values of 
society” (Hudson, K. L., 2006). Concerns expressed about the “slippery slope” potential 
of PGD include the development of two classes of people in the future: the genetically 
enhanced and the non-genetically enhanced.  The average height, intelligence etc. would 
be raised higher, rendering the non-genetically enhanced increasingly at a disadvantage.  
The cost of PGD technology selects for a richer population, making the rich richer with 
genetically enhanced “designer babies” (Brenner, D., & Brutlag, D., 2013; Hudson, K. L., 
2006).   
 
 Another concern expressed by Brenner and Brutlag is related to the welfare of the 
genetically enhanced child.  Talents and life choices of the child might be planned by 
parents before they were born.  A child with higher IQ could be, in the family’s eyes, 
predetermined for a specific role, and failure to achieve such parental expectations might 
result in family issues (Brenner, D., & Brutlag, D., 2013).  Others are concerned about the 
negative implications of “playing God”, which suggests that selecting against disability is 
an act of interfering with nature (Macklin, R., 2010).  The counterargument here is that 
PGD is not more a disruption of nature than most of modern age medicine, where efforts 
to cure disease and to prolong life expectancy are not considered inappropriate.  However, 
Ruth Macklin in 2010 in an article in the journal of Reproductive Medicine supporting 
social sex selection for family balancing, questioned who should have the power to 
regulate such advancements in medicine: the government, professional associations, or 
parents? 
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Laws 
 Some countries have laws that prevent or discourage social sex selection.  Medical 
sex selection in the UK is regulated by the HFEA, which has specific guidelines on the 
genetic conditions for which PGD is permitted.  Clinics in the UK are licensed by the 
HFEA in order to perform PGD (Strange, H., & Chadwick, R., 2010).  Non-medical use 
of PGD for sex selection is illegal in most European countries, including the UK, as well 
as Canada and Australia.  However, there have been reports of couples traveling overseas 
to seek such services (Macklin, R., 2010; Strange, H., & Chadwick, R., 2010).  
 
 In the United States, the American Society for Reproductive Medicine (ASRM) has 
made recommendations regarding non-medical use of PDG for sex selection.  Their ethics 
committee released a statement in 2001 (restated in 2011) saying  “the use of 
preconception sex selection by pre-implantation genetic diagnosis for non-medical 
reasons is ethically problematic and should be discouraged”, but “if prefertilization 
techniques, particularly flow cytometry for sperm sorting, were demonstrated to be safe 
and efficacious, these techniques would be ethically permissible for family balancing. 
Because a pre-implantation genetic diagnosis is physically more burdensome and 
necessarily involves the destruction and discarding of embryos, it was not considered 
similarly permissible for family balancing”.  
 
 The Programme of Action adopted by the United Nations International Conference 
on Population and Development stands against any use of sex selection techniques for any 
non-medical reason, and The United Nations strongly recommend all nations "to take 
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necessary measures to prevent . . . prenatal sex selection.” 
 
 In 2002, health workers in China were banned from telling parents the sex of their 
child.  Recently, China ordered a ban on taking blood samples of pregnant women 
overseas.  It had been found that medical organizations were taking blood samples to 
laboratories out of the country to test for the sex of the baby (Guo, Kai, 2015). The 
authorities in China appear to be taking action to address their population imbalance 
issue; how stringently this will be enforced remains to be seen.   
 
Previous Studies 
 Several studies have attempted to gather information on the views of healthcare 
professionals regarding social sex selection.  A study in 1992 investigated the views of 34 
genetic counselors in the United States regarding fetal sex identification and selective 
abortion, and found that an overwhelming majority of them supported the women’s right 
to early termination, while objecting to prenatal diagnosis for sex selection purposes 
(Burke, B. M., 1994).  Another survey done in 1998 in an international population looked 
at 2903 geneticists’ views on prenatal sex selection (Wilton, L., 2009).  Almost half 
(47%) of the respondents reported receiving open requests for social sex selection, and 
half suspected social sex selection to be a reason for termination although not explicitly 
revealed.   Given a scenario of a family with 4 girls wanting a boy, and willing to 
terminate the pregnancy if another girl was conceived, 29% reported that they would 
perform prenatal diagnosis, and 38% reported that they would offer them referrals.  Four 
other scenarios were also studied.  In each case, the number given in parentheses 
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represents the percentage of geneticists who reported that they  would perform prenatal 
diagnosis in that situation: 1. Single woman wants a girl (35%); 2.Poor couple with five 
boys want a girl (38%); 3. Non-western couple wants a boy (38%); 4. Couple in 40s 
wants a girl (57%).  
 
 A 2006 study by a graduate student at the Sarah Lawrence College Human Genetics 
Program examined the views of genetic counselors on sex selection for non-medical 
proposes (McGuire, M., 2006).  A survey was conducted through the NSGC membership 
listserve and had 240 respondents. A majority (71.5%) objected to the use of ultrasound, 
CVS, or amniocentesis technology for social sex selection, while 45% accepted the use of 
PGD, and 68.7% accepted the use of Microsort® for social sex selection purposes.  
Religion had an influence on the genetic counselors’ acceptance of PGD and sperm 
sorting technologies.  It was also found that the older respondents, and those who had 
children, were more accepting of the use of ultrasound, CVS, or amniocentesis for social 
sex selection.  
 
 This study looks at the views of genetic counselors on the issue of pre-conception 
social sex selection using PGD.  Genetic Counselors, especially those working in the 
preconception specialty, may be the first health care provider that a patient has contact 
with regarding PGD services.  This study looks at how often genetic counselors are faced 
with these situations at this time, and how they feel about counseling patients interested in 
social sex selection.    
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Methods 
 A survey was sent by National Society of Genetic Counselors (NSGC) eblast and 
distributed to its members.  The survey was created through the online website survey 
monkey and approved by the Andrus Institutional Review Board on January 7, 2015. 
Participants answered the survey on a voluntary basis and anonymously. The survey was 
available from January 28, 2015 to February 18, 2015.  
 
 The survey contains 15 questions and took approximately 15 minutes to complete.  
A 5-point Likert scale was used to collect for responses on questions regarding the views 
of genetic counselors toward different prenatal tests and procedures to terminate a 
pregnancy for social sex selection reasons, the potential fears they might have towards 
social sex selection, and their comfort level in counseling patients seeking social sex 
selection in different scenarios. Demographic information was collected regarding age, 
ethnicity, years of experience practicing in the genetic counseling field, and areas of 
expertise.  The data was analyzed using SPSS. 
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Results 
 The initial invitation email was sent to 3209 NSGC members with 244 responses, 
yielding a response rate of 7.6%.  The reminder invitation email was sent to 3236 NSGC 
members with 98 responses, yielding a response rate of 3.0%.  In total, 342 responses 
were received, yielding a response rate of 11%.  Fifty six participants provided additional 
comments. 
Table 1. Patient Contact for Social Sex Selection 
Have you ever had patients ask you about sex selection? 
Answer Options Response Percent n= 
Yes 
54.1% 125 
No 
47.6% 110 
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Chart 1.  Frequency of Patient Contact 
 
 
Chart 2. Patient Demographic Information 
 
 
 
 
 
 
60%	  n=75	  18%	  n=22	  
10%	  n=12	  
12%	  n=15	  
How	  often	  you	  had	  patients	  ask	  about	  sex	  selection	  	  
Rarely	  Once	  in	  a	  while	  Sometimes	  Frequently	  
0	  10	  20	  
30	  40	  50	  
60	  70	  80	  
Ethinic	  Groups	  and	  the	  Sex	  Selected	  as	  
Seen	  in	  Clinic	  
Girl	  Boy	  
	   	   	  12	  
Table 2.  Opinion on Pregnancy Termination 
For the following statements, choose “Strongly Agree”, “ Agree”, “Neutral”, “Disagree”, or “Strongly Disagree”. 
Answer Options Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
*Rating 
Average 
Response Count 
Terminating a pregnancy following 
amniocentesis or CVS for purposes 
of sex selection is acceptable. 
1.9% 
(n=4) 
 
4.8% 
(n=10) 
17% 
(n=37) 
37% 
(n=79) 
38% 
(n=81) 
1.9 211 
A mother or couple has the right to 
terminate a pregnancy for sex 
selection following an 
amniocentesis or CVS. 
15% 
(n=31) 
49% 
(n=103) 
19% 
(n=41) 
5.7% 
(n=12) 
11% 
(n=24) 
3.5 211 
Terminating a pregnancy following 
non-invasive prenatal testing in the 
first trimester for the purpose of 
sex selection is acceptable. 
1.4% 
(n=3) 
4.2% 
(n=9) 
14% 
(n=30) 
34% 
(n=72) 
46% 
(n=97) 
1.8 211 
A mother or couple has the right to 
terminate a pregnancy for sex 
selection following non-invasive 
prenatal testing in the first 
trimester. 
14% 
(n=30) 
42% 
(n=88) 
17% 
(n=36) 
12% 
(n=25) 
15% 
(n=32) 
3.3 211 
Using PGD to choose embryos for 
purposes of sex selection is 
acceptable. 
3.8% 
(n=8) 
24% 
(n=51) 
28% 
(n=59) 
24% 
(n=50) 
20% 
(n=41) 
2.7 209 
A mother or couple has the right to 
use PGD to choose embryos for the 
purpose of sex selection. 
17% 
(n=31) 
46% 
(n=98) 
22% 
(n=46) 
9.5% 
(n=20) 
7.6% 
(n=16) 
3.5 211 
Sex selection to prevent X-linked 
disease is a good use of PGD. 
59% 
(n=123) 
36% 
(n=75) 
3.8% 
(n=8) 
1.4% 
(n=3) 
0.48% 
(n=1) 
4.5 210 
Sex selection for family balancing 
is a good use of PGD. 
1.9% 
(n=4) 
9.0% 
(n=19) 
26% 
(n=55) 
34% 
(n=71) 
29% 
(n=62) 
2.2 211 
Sex selection to provide a first 
child of a specific sex is a good use 
of PGD. 
1.4% 
(n=3) 
4.3% 
(n=9) 
20% 
(n=42) 
37% 
(n=79) 
37% 
(n=78) 
2.0 211 
* (1=Strongly Disagree, 2= Disagree, 3=Neutral 4=Agree, 5=Strongly Agree) 
 
 
 
 
 
 
 
 
	   	   	  13	  
Table 3. Possible Concerns Regarding Social Sex Selection 
Which of the following issues affects how you view sex selection? (Check all that apply): 
Answer Options Response 
Percent 
n= 
Sex selection reflects prejudice against women in the 
US/Canada 
26% 53 
Sex selection reflects prejudice against women in other 
cultures 
63% 127 
Parents should not be able to use technology to choose 
traits 
47% 95 
Sex selection might lead to other, more offensive types 
of trait selection 
70% 142 
Sex selection may create a male-female population 
imbalance in other countries 
53% 108 
Sex selection may create a male-female population 
imbalance in the US/Canada 
25% 51 
I don’t have any opposition to social sex selection 8.9% 18 
Total Response 203 
 
Table 4. Concerns Regarding Social Sex Selection 
Which of these is the most important issue? 
Answer Options Response 
Percent 
n= 
Sex selection reflects prejudice against women in the 
US/Canada 
3% 6 
Sex selection reflects prejudice against women in other 
cultures 
19% 37 
Parents should not be able to use technology to choose 
traits 
26% 52 
Sex selection might lead to other, more offensive types 
of trait selection 
36% 72 
Sex selection may create a male-female population 
imbalance in other countries 
7.0% 14 
Sex selection may create a male-female population 
imbalance in the US/Canada 
1% 2 
I don’t have any opposition to social sex selection 8.0% 16 
Total Response 199 
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Table 5.  Views on Future Use of PGD  
Do you have any fears about potential downstream negative effects of allowing sex 
selection using PGD? 
Answer Options Response 
Percent 
Response 
Count 
Yes, I am very worried 14% 28 
Yes, I am somewhat worried 50% 102 
I am not sure 24% 49 
No, I am somewhat comfortable 9% 19 
No, I am comfortable 3% 7 
Total Response 205 
 
Table 6. Concern about Trait Selection 
I believe the use of reproductive technology to select traits is likely to become more 
commonplace over time. 
Answer Options Response 
Percent 
Response 
Count 
True 72% 148 
False 28% 57 
Total Response 205 
 
Table 7. Potential Factors Affecting Patient Contact  
Answer Options No problem Comfortable Somewhat 
comfortable 
Not 
comfortable 
Would not 
counsel 
*Rating 
Average 
A 50-year-old European 
couple wanting a firstborn 
son. 
6.4% 
(n=13) 
13% 
(n=26) 
26% 
(n=53) 
42% 
(n=84) 
13% 
(n=26) 
3.4 
A 50-year-old Asian couple 
wanting a firstborn son. 
6.4% 
(n=13) 
13% 
(n=26) 
27% 
(n=54) 
41% 
(n=83) 
13% 
(n=26) 
3.4 
A 50-year-old couple 
wanting a firstborn daughter. 
6.4% 
(n=13) 
13% 
(n=27) 
26% 
(n=53) 
41% 
(n=83) 
13% 
(n=26) 
3.4 
A 25-year-old European 
couple wanting a firstborn 
son. 
6.4% 
(n=13) 
14% 
(n=28) 
25% 
(n=51) 
41% 
(n=82) 
14% 
(n=28) 
3.4 
A 25-year-old Asian couple 
wanting a firstborn son. 
6.4% 
(n=13) 
14% 
(n=28) 
25% 
(n=50) 
41% 
(n=83) 
14% 
(n=28) 
3.4 
A 25-year-old couple 
wanting a firstborn daughter. 
6.4% 
(n=13) 
14% 
(n=29) 
26% 
(n=52) 
40% 
(n=80) 
14% 
(n=28) 
3.4 
A single woman wanting a 
firstborn son. 
6.4% 
(n=13) 
14% 
(n=29) 
26% 
(n=52) 
40% 
(n=81) 
13% 
(n=27) 
3.4 
Total Response 202 
* (1=no problem, 2= comfortable, 3=somewhat comfortable 4=not comfortable, 5=would not counsel) 
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Discussion 
 The results from our survey suggest that there is an increase in the number of 
patients seeking social sex selection since 2006.  In a 2006 survey of the NSGC 
membership, 4% of the respondents said they saw patients seeking genetic counseling 
services requesting social sex selection either “sometimes” or “frequently”.  In the current 
study, 22% of respondents (Chart 1) reported seeing patients seeking social sex selection 
either “sometimes” (10%, n=12) or “frequently” (12%, n=15).  This suggests about a five-
time increase in the number of patients seeking this service from genetic counselors.   
 
 As the literature predicts, culture and ethnicity were factors impacting who was 
seeking to use PGD for sex selection and their preferred sex.  When asked to describe the 
scenarios they had encountered, counselors were most likely to report seeing Indian 
(n=67) or Chinese (n=59) patients requesting sex selection (Chart 2).  The data also 
suggests that this group of patients were more likely to select for boys.  They reported 
seeing more than five times as many requests for selection in favor of boys than girls in 
these two groups, while, for example, Northern European’s requests were not uncommon 
(n=52) but sex preferences were evenly split.  Several additional comments in this section 
suggests that European couples were seeking social sex selection services for family 
balancing reasons, which stands in contrast to the sex-biased preferences reflected 
elsewhere. 
 
Results of the study suggest that a majority of genetic counselors do not agree 
with using prenatal medical tests and procedures for social sex selection (Table 2). Most 
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respondents disagreed or strongly disagreed with the statement “sex selection for family 
balancing is a good use of PGD” (63%, n=133) and disagreed or strongly disagreed with 
the statement “Sex selection to provide a first child of a specific sex is a good use of 
PGD” (74%, n=157). Counselors were somewhat sensitive to issues of timing, and far 
more respondents agreed or strongly agreed that using PGD to select for embryos to 
choose sex was acceptable (27.8%, n=59) than agreed or strongly agreed that termination 
following amniocentesis or CVS for purposes of sex selection was acceptable (6.7%, 
n=12).  Overall, responses suggest that the respondents were uncomfortable with the idea 
of sex selection at any point before or during pregnancy. 
 
Despite this, a majority of genetic counselors voiced support for the right of 
patients to terminate a pregnancy for sex selection reasons. Respondents supported the 
right of a patient to terminate a pregnancy for social sex selection, independent of the 
prenatal test or procedure used to obtain the information on the sex of the baby.  Over half 
of the respondents agreed with the statement “a mother or couple has the right to 
terminate a pregnancy for sex selection following an amniocentesis or CVS” (64%, 
n=134), and the statement “a mother or couple has the right to use PGD to choose 
embryos for the purpose of sex selection” (61%, n=129).  Overall, respondents were 
supportive of all statements about a woman’s and couple’s right to make any of these 
choices, even when they had not rated them as acceptable or a good use of the testing. 
This likely indicates a strong support for abortion rights, and the right to terminate a 
pregnancy for any reason.  Comments like these by respondents supported this 
interpretation:  
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“I fully support the right to reproductive choice in our country even when it goes 
against my personal values. So, while I wouldn't want to be complicit in sex selection, I 
would still support their right.”  
“I don't think anybody likes the idea of terminating a healthy pregnancy, but 
individuals have the right to terminate a pregnancy up to certain time points for any 
reason.”  
“In the long run, although I don't think sex selection SHOULD be practiced, a 
couple can choose to terminate a pregnancy for ANY reason, or no reason at all. It is not 
up to my judgment to put limitations on that right or to be judgmental about their 
culture.” 
 
 Responses to questions that specifically mentioned non-invasive prenatal screening 
(NIPS) showed a small but consistent increased concern about the use of that procedure 
for purposes of sex selection as compared to later procedures, which is counter-intuitive.  
Participants responded negatively to a statement that it was “acceptable” to terminate for 
sex selection purposes after amniocentesis or CVS (average score 1.9) but even more 
negatively to an identically worded statement about NIPS (average score 1.8), and more 
respondents ‘strongly disagreed’ with the statement about NIPS (46%, n=97) than 
strongly disagreed with the statement about amniocentesis or CVS (38%, n=81).  Again, a 
slightly smaller number of respondents agreed or strongly agreed to the statement “a 
mother or couple has the right to terminate a pregnancy for sex selection following non 
invasive testing in the first trimester” (56%, n=118) than  agreed or strongly agreed to the 
statements “a mother or couple has the right to use PGD to choose embryos for the 
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purpose of sex selection” (61%, n=129), or “a mother or couple has the right to terminate 
a pregnancy for sex selection following amniocentesis or CVS” (63%, n=134).   This 
result was unexpected considering the timing of the procedures, since NIPS is the earlier 
prenatal test. While the differences are small, it may suggest that the respondents were 
concerned about the potential eugenic implications of the newer procedure in providing 
information about the sex of the baby in the first trimester. 
 
 Respondents were unambivalent about the use of PGD for medical purposes.  
Genetic counselors approved medical uses by a wide margin:  95% (n=198) of the 
respondents agreed or strongly agreed with the statement “sex selection to prevent x-
linked disease is a good use of PGD”. 
 
 A majority of genetic counselors (64%, n=130) expressed that they were either 
“somewhat worried” or “very worried” about the downstream implications of sex 
selection (Table 5).  Most (72%, n=148) believed the practice would become more 
common over time (Table 6).  Specific concerns varied, and included sexism towards 
women, creating a population imbalance, and a range of ‘slippery slope’ issues (Table 3).   
 
 Counselors showed the greatest concern about the potential that sex selection could 
be a ‘slippery slope’ issue (Table 4).  When asked to indicate which of a list of concerns 
affected how they viewed sex selection, 70% of respondents (n=142) indicated that it 
“could lead to other, more offensive forms of trait selection” (Table 3), an increase over 
the 2006 study where 54% of respondents either “strongly agreed” or “agreed” with the 
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statement “I am concerned that gender selection will serve as the ‘slippery slope’ for 
selecting for other non medical traits such as intelligence and athletic ability”.   In 
addition, 47% of respondents (n=95) expressed a related concern that “parents should not 
be able to use technology to choose traits”.  When asked what concerned them the most, 
36% (n=72) chose trait selection and 26% (n=52) pointed to parents choosing traits (Table 
4).  Combined, these responses suggest that respondents were extremely concerned about 
the implications of being able to use PGD for non-medical purposes as use of the 
technology increases. 
 
 A significant number of genetic counselors expressed concerns about sexism, but it 
was not their primary concern related to sex selection.  A majority of respondents (63%, 
n=127) included “sex selection reflects prejudice against women in other cultures” when 
asked to indicate which of a list of concerns affected how they viewed sex selection, and 
26% (n=53) included “sex selection reflects prejudice against women in the US/Canada” 
(Table 3).  This response suggests that genetic counselors are aware of and concerned 
about the issue of sex selection in cultures that favor boys, and where selection against 
girls has resulted in population imbalances, however, when asked to indicate which one of 
the same list of concerns they felt was the most important, only a minority of respondents 
chose sexism against women in other cultures (19%, n=37), and even fewer chose sexism 
against women in the US and Canada (3.0%, n=6) (Table 4). 
 
 A series of questions were designed to investigate the comfort level of genetic 
counselors with different scenarios involving social sex selection, in order to investigate 
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the degree to which the motivation and ethnicity of patients would be factors that would 
affect the behavior or thinking of genetic counselors (Table 7). Scenarios varied as to the 
age, ethnicity and marital status of the patients, as well as the number and sex of existing 
siblings.  Respondents described their comfort level in all scenarios as somewhere in 
between “somewhat uncomfortable” and “not comfortable” in every scenario, indicating 
that they are uneasy with the use of social sex selection, and that this uneasiness is not a 
function of circumstances. 
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Conclusion 
Preimplanatation genetic diagnosis (PGD) started as a medical procedure to select 
for embryos at risk of X-linked diseases, however, use to select for the sex of the embryos 
for non-medical reasons is increasing. This emerging use has stirred ethical debates 
regarding sexism, population imbalance, gender stereotyping, legal issues, and the fear of 
a slippery slope toward the use of genetic testing for trait selection more generally.   
 
Overall, this study suggests that genetic counselors do not support or approve of 
the use of PGD for social sex selection purposes, regardless of the type of testing used or 
the point at which selection occurs.  Their biggest concern regarding the use of PGD for 
sex selection is the concern that it will lead to an increased use of PGD for trait selection 
in general.  Meanwhile, conflictingly, genetic counselors show a strong belief in the right 
of all patients to terminate a pregnancy even for purposes of social sex selection.  The 
field of genetic counseling may wish to consider how uses of PGD like sex selection can 
be discouraged without creating policies that limit the rights of women and couples to 
reproductive rights including termination. 
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